Search Results 581-590 of 17831 for Coagulation

  1. Doctors and departments - Mayo Clinic

    Mayo Clinic healthcare professionals actively study potential treatments for coarctation of the aorta and other heart conditions. Learn more about research in ...

  2. Omega-3 Fatty Acids and Insulin Sensitivity - Mayo Clinic

    Anti-coagulant therapy (warfarin/heparin); INR >3; Use of systemic glucocorticoids; Chronic use of NSAIDS or aspirin; Pregnancy or breastfeeding; Alcohol ...

  3. Study of Treg Therapy in Subclinical Inflammation in Kidney Transplantation (TASK) - Mayo Clinic

    Any chronic illness requiring uninterrupted anti-coagulation after kidney transplantation. Post-transplant DSA > 5000 MFI or post-transplant treatment with ...

  4. Conjugated estrogens (oral route) - Side effects & dosage - Mayo Clinic

    It is used to treat moderate to severe hot flashes, changes in and around the vagina, and other symptoms of menopause or low amounts of estrogen ( ...

  5. TRC-PAD Program: In-Clinic Trial-Ready Cohort

    ... coagulation (e.g. warfarin). Participants whom the Site PI deems to be otherwise ineligible. Participating Mayo Clinic locations. Study statuses change often ...

  6. 221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease - Mayo Clinic

    History of bleeding disorder or predisposing conditions, blood clotting or clinically significant abnormal results on coagulation profile at Screening, as ...

  7. A Phase 1/​2 Study of STP938 for Adult Subjects With Relapsed/​Refractory B-Cell and T-Cell Lymphomas - Mayo Clinic

    - Adequate organ function (bone marrow, hepatic, renal function and coagulation). - All toxicities (except alopecia) from prior cancer treatments or ...

  8. Oncology (Medical) - Doctors - Mayo Clinic

    ... coagulation, Bleeding disorder, Benign hematologic condition, Autoimmune hemolytic anemia, Paroxysmal nocturnal hemoglobinuria, Myeloproliferative disorders ...

  9. A Study of PY314 in Subjects With Advanced Solid Tumors - Mayo Clinic

    - Coagulation: International Normalized Ratio (INR) ≤ 1.3, unless on a therapeutic anticoagulant - Adequate hematologic function defined as follows ...

  10. Study of E7386 in Participants With Selected Advanced Neoplasms - Mayo Clinic

    - Adequate blood coagulation function as evidenced by an International Normalized Ratio (INR) ≤ 1.5 (in the absence of therapeutic anticoagulation);